Search results
Found 10515 matches for
Researchers at the MRC Weatherall Institute of Molecular Medicine have recently discovered why a class of cancer drugs is beneficial only in a subset of patients. The results could pave the way for the future development of these drugs, known as PNP-inhibitors, as personalised medicines.
Anindita Roy
Group Leaders MRC MHU
MRCPCH FRCPath PhD Anindita Roy - Professor of Paediatric Haematology
Lance Hentges
Centre for Computational Biology Researchers
DPhil Lance Hentges - Postdoctoral Scientist
Michalina Mazurczyk
Facilities Staff MRC TIDU
BSc. MSc. Michalina Mazurczyk - Flow/Mass Cytometry Specialist
Aleksandr Sahakyan
Centre for Computational Biology Group Leaders
Aleksandr Sahakyan - MRC WIMM Group Leader and Principal Investigator in RDM
Andrew Armitage
MRC TIDU Researchers
M.Biochem, D.Phil Andrew Armitage - Senior Postdoctoral Scientist
Timothy Rostron
Facilities Staff MRC TIDU
BSc; MSc Timothy Rostron - Sequencing and HLA Typing Laboratory Manager
Asger Jakobsen
MRC MHU Researchers
BMBCh, MRCP, DPhil Asger Jakobsen - Postdoctoral Clinical Research Fellow